Endoscopic-Assisted Drug Delivery for Inner Ear Regeneration.
| Autor: | Kempfle JS; Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Eaton-Peabody Laboratories, C360, 243 Charles Street, Boston, MA 02114, USA. Electronic address: Judith_Kempfle@MEEI.HARVARD.EDU. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Otolaryngologic clinics of North America [Otolaryngol Clin North Am] 2021 Feb; Vol. 54 (1), pp. 189-200. |
| DOI: | 10.1016/j.otc.2020.09.022 |
| Abstrakt: | Sensorineural hearing loss is caused by irreversible loss of auditory hair cells and/or neurons and is increasing in prevalence. Hair cells and neurons do not regenerate after damage, but novel regeneration therapies based on small molecule drugs, gene therapy, and cell replacement strategies offer promising therapeutic options. Endogenous and exogenous regeneration techniques are discussed in context of their feasibility for hair cell and neuron regeneration. Gene therapy and treatment of synaptopathy represent promising future therapies. Minimally invasive endoscopic ear surgery offers a viable approach to aid in delivery of pharmacologic compounds, cells, or viral vectors to the inner ear for all of these techniques. Competing Interests: Disclosure Consultant, Boston Pharmaceuticals. (Copyright © 2020 Elsevier Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|